FDA Inspection 1199733 — Natalie D. Duric, MD
The FDA completed an inspection of Natalie D. Duric, MD on February 16, 2023 in Gwaelod Y Garth. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 16, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Gwaelod Y Garth (United Kingdom)
Additional Details
Clinical Investigator (CI)